Products
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Usage-based
No monthly subscription pricing
Creators
IMBX
@imbxio· 321 followers
Launched
21mo ago
2025-03-11 · Est.

Traffic

Monthly visitsData through Oct 2026
Events4 changes

Marketing moves

Launches, search & content, referrals, promotions
X accounts@imbxio
  • New product launchLaunch

    Mar 11, 2025 · 21mo agoWebsite

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-03-11

KeywordMonthly volume
imbx370

Traffic data: Vaneform

Pricing

Usage-based pricing; no fixed plans listed on website.

Trial: None · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-11-04

Key pages

Weekly snapshots
www.imbx.io/ Snapshot 2026-11-06

Changes

  1. Nov 1 · 18d ago

    Homepage headline (H1) changed to “Build your position”Positioning

    1 How Do I Create And Verify My Account On IMBX?→Build your position

    At the time: <5K visits/mo3 concurrent moves
  2. Nov 1 · 18d ago

    Removed technology: LiveChatFeatures

    LiveChat→—

    At the time: <5K visits/mo3 concurrent moves
  3. Nov 1 · 18d ago

    Adopted technology: ZendeskFeatures

    —→Zendesk

    At the time: <5K visits/mo3 concurrent moves
  4. Nov 1 · 18d ago

    Adopted technology: core-jsFeatures

    —→core-js

    At the time: <5K visits/mo3 concurrent moves

Questions & evidence

How much website traffic does IMBX get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is IMBX and what platforms does it support?
IMBX is catalogued under Crypto Wallets & Trading: Build your position. Supported platforms: Mobile App, API.

Related products in this category

Finance / Crypto Wallets & Trading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.